about the author

Emma Yasinski

emma@endpointsnews.com

author articles

Nicox shares soar on Zervi­ate OK; Gem­phire CEO re­signs; Ar­ray, Ono team up on a $187M deal

8 years ago
News Briefing

Scripps re­searchers add pow­er to an­tibi­ot­ic van­comycin, giv­ing it a third mech­a­nism to fight su­per­bugs

8 years ago
R&D

MannKind el­e­vates Cas­tan­ga to CEO; 23andMe re­cruits 5,000 women for study in 9 days

8 years ago
News Briefing

Alex­ion CEO re­boots lead­er­ship team; Juno adds for­mer Il­lu­mi­na CEO to its board

8 years ago
Peer Review

Venn and Uni­ver­si­ty of Utah part­ner on im­muno-on­col­o­gy mol­e­cule; Bio­gen los­ing an­oth­er ex­ec

8 years ago
News Briefing

New car­dio tar­get ANGPTL3 with promis­ing new stud­ies; Liv­er­pool says Redx is delin­quent; Aslan's $33M Taipei IPO

8 years ago
News Briefing

Im­muno­Gen gets $25M up­front for ADC ther­a­py; mi­Ra­gen adds Eu­ro­pean or­phan drug des­ig­na­tion; Pierre Fab­re buys some ...

8 years ago
News Briefing
First page Previous page 12
A service from the Financial Times